Moreover, exploring whether TRPC6 antagonists can enhance the effectiveness of common gastric cancer chemotherapeutic agents, including paclitaxel and cisplatin, holds promise (Almasi et al., 2018). The gene discussed is TRPC6; the disease is gastric cancer.